World Alzheimer Congress 2000, an international gathering of experts in Alzheimer’s disease, is scheduled to take place next month in Washington, D.C. The goal of this major gathering is to share knowledge, research, and key strategies for putting an end to Alzheimer’s.
Participants in the event, which promises to be the largest ever held for professionals dedicated to Alzheimer’s, hopes to raise awareness of research, treatment and other issues associated with the degenerative disease. Meetings such as this are key to attract funding for future research and to educate the public about prevention and possible medical treatments.
The convention will target three main areas featuring internationally renowned experts. Pivotal Research will focus on the latest scientific research into the causes, mechanisms and therapeutic approaches to Alzheimer’s. The section will feature an update on a potential vaccine as well as other advances in the research aspect of the disease. An estimated twelve hundred presentations are scheduled for this five-day section of the event.
Bridging Research and Care will be a two-day session on diagnoses, treatment and care for people already suffering from Alzheimer’s. The complex social aspects of dealing with the disease will be explored, including ways for physicians to present a diagnosis to family members.
Creative Care will comprise the final segment of the conference with an in-depth look at caregiving issues. Presentations will cover caregiving from various professionals and will focus on sharing information. The participants hope to foster a creative approach to caregiving issues by exploring themes such as the global impact of dementia, the practical application of research, the early needs of families and patients, and reaching out to minority populations.
The conference is sponsored by the Alzheimer’s Association (U.S.A.), Alzheimer’s Disease International and the Alzheimer Society of Canada. Hopefully, this will mark the first of many similar events devoted to further understanding of this disease. For more information contact: